Searched for
PSORIASIS DRUG TRIAL
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Sun Pharma’s Ilumya expansion bid gets USFDA nod for reviewSun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for t...
- Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trialsSun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for ...
- Biocon Biologics inks licence pact with Janssen for biosimilar productThe agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Bioco...
- Biocon defends limited trial patients for Itolizumab nod, says followed science of "highest order"The company is marketing the drug as a replacement to Roche Pharma’s Tocilizumab (originally approved for rheumatoid arthritis) that is cur...
- Biocon jumps 10%, hits 52-week high as DCGI approves use of Itolizumab on Covid-19 patientsThe drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in In...
- Drug regulator okays psoriasis injection for limited use in treating COVID-19 patientsConsidering the unmet medical needs to treat COVID-19, Drugs Controller General of India Dr V G Somani approved monoclonal antibody injecti...
- US FDA accepts application for psoriasis drug: Sun PharmaThe FDA filing acceptance follows the acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency (EMA) in March ...
- Almirall seeks nod for tildrakizumab in Europe: Sun PharmaThe filing includes efficacy and safety data from the pivotal Phase III clinical trials that included over 1,800 patients across more than ...
- Sun Pharma announces details of psoriasis drug trialsTildrakizumab is a monoclonal antibody designed to control the pathogenic cells responsible for the inflammatory process of psoriasis with ...
- Sun Pharma signs licening pact with spanish firm Almirall for psoriasis drugIn return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...
- Nine new drugs under clinical stage: Dr Reddy'sAccording to a filing with US SEC, the drug maker said as of March 31, 2014, it had 20 active products in the proprietary products pipeline.
- Biocon rolls out its first biologic drug for the treatment of psoriasisCalled ALZUMAb, it took 10 years in the making and "is recognition of innovation done by research and development wing of Biocon," said Kir...
- Six new drugs in clinical development stage: Dr Reddy'sThe drug maker said as of March 31, 2013, DRL had 21 active products in the proprietary products pipeline, of which six are in clinical dev...
- Looking for global partner for psoriasis drug: Kiran Mazumdar Shaw, BioconThe plan is that the India drug will launched as an intravenous infusion and it has been indicated for psoriasis, says Kiran Mazumdar Shaw.
- Biocon to come out with new drug for treating PsoriasisBiocon today said it will soon come out with a new drug for treating inflammatory skin disease Psoriasis as the first clinical trial of the...
- Heard on the Street: Fund stocks up Biocon on drug launch buzzA large fund house belonging to a business conglomerate has been accumulating biotechnology company Biocon over the past two weeks on drug ...
- 'Lupin can conduct anti-psoriasis clinical trials'Lupin has received approval from the Drugs Controller General (India) to conduct a combined phase-IIb/III clinical trial for its herbal ant...
- Lupin gets DCGI nod for anti-psoriasis clinical trialsLupin has received approval from the Drugs Controller General (India) to conduct a combined phase-IIb/III clinical trial for its herbal ant...
- Govt to share Lupin's migraineThe government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...
Load More
